Swiss Life tient à vous offrir le meilleur service possible en tout temps. Afin que vous puissiez faire un usage optimal de notre site Web et que nous puissions continuellement l’améliorer, nous utilisons des cookies. En continuant à utiliser le site Web, vous consentez à l’usage de cookies.

Liquidation Swiss Life Funds (LUX) Equity Biomedical


Dear Shareholder,
We hereby inform you that the board of directors (the “Directors”) of Swiss Life Funds (LUX) (the
“Company”) intends, in accordance with Article 24 of the articles of incorporation of the Company, to liquidate the sub-fund Swiss Life Funds (LUX) - Equity Biomedical (the “Sub-Fund”) on 23 February 2011 (the “Liquidation Date”). Accordingly no new subscription into the Sub-Fund will be allowed from the date of this notice.